Home » Newsletters » BioWorld Science

BioWorld Science

June 29, 2015

View Archived Issues

Pivotal phase III trial of galeterone for metastatic castration-resistant prostate cancer

FDA grants BLZ-100 orphan status for visualizing brain tumors

Celator Pharmaceuticals reports induction response data from phase III study of CPX-351

ESHG highlights: characterization of disease-associated gene mutations

Perle studies combination of oral cyclosporine and lansoprazole for type 1 diabetes

NIAAA initiates trial of Horizant for alcohol use disorder

Novogen advances anisina towards clinic

Scripps Research Institute receives NIH grant for novel diabetes treatments

Radicut approved in Japan for amyotrophic lateral sclerosis

VIB and Vrije Universiteit Brussel spin out Confo Therapeutics

Trial finds RVX-208 may benefit individuals with prediabetes

Zosyn receives approval for the additional indication of febrile neutropenia in Japan

Humira recommended for approval for hidradenitis suppurativa in E.U.

Enrollment begins in global phase Ib study of QR-010 in cystic fibrosis

CHMP adopts positive opinions for Strensiq and Kanuma

Farydak recommended by CHMP to treat multiple myeloma

UCB seeks Japanese approval for lacosamide for partial onset seizures

EMA committee recommends approval of Raxone for Leber's hereditary optic neuropathy

RepliCel describes the potential of cell therapies to treat tendinosis and aging skin

European approval of Simponi for non-radiographic axial spondyloarthritis

Aurigene Discovery Technologies discloses RORgamma modulators

Merck & Co. reports development of gamma-secretase inhibitors

Baylor College of Medicine and Elex Biotech report RyR2/FKBP12.6 complex antagonists

AbbVie develops bromodomain inhibitors

Allergan synthesizes S1P1 ligands

Phase I data influence future development of LY-3022856

Immunomodulatory progenitor cells show promise to mitigate ICR in heart failure

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.